Literature DB >> 6268545

Differentiation of members of the human herpesviridae family by radioimmunoassay.

K O Smith, W Kennell.   

Abstract

Many individuals who are seronegative for one member of the human Herpesviridae family are strongly seropositive for other members. Using sera from such individuals, the radioimmunoassay technique demonstrated absence of antigen-antibody cross-reactions between varicella-zoster virus (VZV) and herpes simplex virus (HSV) at levels of less than one part in 1,000. Sera containing antibody to both HSV and VZV were absorbed with antigens of one agent without significantly altering the amount of remaining antibody to the other antigen. This further suggests that HSV and VZV do not share a common antigen. The same radioimmunoassay technique and serum absorption method that revealed no serological cross-reactions between HSV and VZV revealed the expected cross-reaction between HSV type 1 (HSV-1) and HSV-2. Reciprocally absorbed anti-HSV-1 and anti-HSV 2 sera were able to differentiate the two HSV types reliably. No cross-reactions were seen between cytomegalovirus, VZV, and HSV or between Epstein-Barr virus, VZV, and HSV. We postulate that heterotypic antibody responses sometimes observed for VZV after primary infections by HSV may not be due to shared antigens, but to activation of latent VZV infections, release of new VZV antigens, and consequent stimulation of new antibody production to VZV.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268545      PMCID: PMC350725          DOI: 10.1128/iai.33.2.491-497.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  POSSIBLE ANTIGENIC RELATIONSHIP BETWEEN VARICELLA ZOSTER VIRUS AND HERPES SIMPLEX VIRUS.

Authors:  J G KAPSENBERG
Journal:  Arch Gesamte Virusforsch       Date:  1964-09-09

2.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

3.  Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.

Authors:  C L Wong; S Castriciano; M A Chernesky; W E Rawls
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

4.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

5.  Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.

Authors:  G J Schaap; J Huisman
Journal:  Arch Gesamte Virusforsch       Date:  1968

6.  Varicella virus in HeLa cells.

Authors:  A Svedmyr
Journal:  Arch Gesamte Virusforsch       Date:  1965

7.  Neutralizing antibody responses to varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.

Authors:  A M Arvin; C M Koropchak
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

View more
  3 in total

1.  Comparison of immunofluorescence with commercial monoclonal antibodies to biochemical and biological techniques for typing clinical herpes simplex virus isolates.

Authors:  E S Balkovic; G D Hsiung
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

2.  A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2.

Authors:  K O Smith; K S Galloway; W L Kennell; K K Ogilvie; B K Radatus
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

3.  Comparison of biological, biochemical, immunological, and immunochemical techniques for typing herpes simplex virus isolates.

Authors:  Z M Zheng; D R Mayo; G D Hsiung
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.